Lenox Hill Trial Investigates If Immunotherapy Can Stop or Slow Growth of Head and Neck Cancer
June 13, 2020
June 13, 2020
GREAT NECK, New York, June 13 -- Northwell Health issued the following news:
Trial seeks head and neck squamous cell carcinoma patients
Lenox Hill Hospital is currently recruiting patients for an international clinical trial investigating whether an immunotherapy medication called pembrolizumab may help stop or slow down the growth of head and neck squamous cell carcinoma (HNSCC). At Lenox Hill, the study is being led by principal investigator Dennis Kraus, MD, vice cha . . .
Trial seeks head and neck squamous cell carcinoma patients
Lenox Hill Hospital is currently recruiting patients for an international clinical trial investigating whether an immunotherapy medication called pembrolizumab may help stop or slow down the growth of head and neck squamous cell carcinoma (HNSCC). At Lenox Hill, the study is being led by principal investigator Dennis Kraus, MD, vice cha . . .